We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODI icon
2101
Compass Diversified
CODI
$828M
$3.36M ﹤0.01%
184,289
-26,681
-13% -$501K
GOGL
2102
DELISTED
Golden Ocean Group
GOGL
$3.35M ﹤0.01%
367,842
-59,375
-14% -$516K
EZPW icon
2103
Ezcorp Inc
EZPW
$1.71B
$3.35M ﹤0.01%
410,946
+112,144
+38% +$1,000K
CRAI icon
2104
CRA International
CRAI
$1.06B
$3.35M ﹤0.01%
27,330
+7,320
+37% +$806K
DCOM icon
2105
Dime Commercial Bancshares
DCOM
$1.78B
$3.35M ﹤0.01%
105,124
-14,468
-12% -$477K
GBX icon
2106
The Greenbrier Companies
GBX
$1.46B
$3.35M ﹤0.01%
99,761
-15,385
-13% -$512K
RFP
2107
DELISTED
Resolute Forest Products Inc.
RFP
$3.33M ﹤0.01%
154,391
-21,649
-12% -$453K
TNC icon
2108
Tennant Co
TNC
$1.26B
$3.33M ﹤0.01%
53,991
-5,588
-9% -$342K
RTL
2109
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$3.32M ﹤0.01%
560,590
-72,512
-11% -$461K
FCEL icon
2110
FuelCell Energy
FCEL
$1.63B
$3.32M ﹤0.01%
39,847
-3,840
-9% -$370K
HWKN icon
2111
Hawkins
HWKN
$2.71B
$3.32M ﹤0.01%
86,055
-850
-1% -$35K
SKIN icon
2112
SkinHealth Systems
SKIN
$85.7M
$3.32M ﹤0.01%
364,882
+49,547
+16% +$535K
VMEO
2113
DELISTED
Vimeo
VMEO
$3.31M ﹤0.01%
966,509
+269,432
+39% +$1.04M
AMTB icon
2114
Amerant Bancorp
AMTB
$1.13B
$3.31M ﹤0.01%
123,122
-5,440
-4% -$153K
XMTR icon
2115
Xometry
XMTR
$5.34B
$3.3M ﹤0.01%
102,313
-3,952
-4% -$185K
DDS icon
2116
Dillards
DDS
$9.56B
$3.29M ﹤0.01%
10,189
-573
-5% -$186K
SB icon
2117
Safe Bulkers
SB
$774M
$3.29M ﹤0.01%
1,131,659
+296,068
+35% +$820K
OSBC icon
2118
Old Second Bancorp
OSBC
$1.29B
$3.25M ﹤0.01%
202,875
+11,741
+6% +$188K
ATRI
2119
DELISTED
Atrion Corp
ATRI
$3.24M ﹤0.01%
5,791
+1,505
+35% +$909K
TFIN icon
2120
Triumph Financial Inc
TFIN
$1.82B
$3.24M ﹤0.01%
66,289
-9,170
-12% -$495K
CNM icon
2121
Core & Main
CNM
$8.71B
$3.22M ﹤0.01%
166,794
+10,591
+7% +$226K
TMP icon
2122
Tompkins Financial
TMP
$1.42B
$3.22M ﹤0.01%
41,485
-7,396
-15% -$589K
BFC icon
2123
Bank First Corp
BFC
$1.7B
$3.19M ﹤0.01%
34,414
-239
-0.7% -$21.2K
UPST icon
2124
Upstart Holdings
UPST
$3.03B
$3.19M ﹤0.01%
241,546
+19,957
+9% +$386K
INO icon
2125
Inovio Pharmaceuticals
INO
$69M
$3.19M ﹤0.01%
170,373
+73,695
+76% +$1.67M

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.